Abstract:TNF-receptor-associated factors (TRAFs) are intracellular proteins that bind to the cytoplasmic portion of TNF receptors and mediate downstream signaling. The six known TRAF proteins play overlapping yet distinct roles in controlling immune responses as well as cellular processes such as activation of NF-κB and JNK signaling pathways. For example, CD40 binds to TRAF2, TRAF3 and TRAF6 to control B cell differentiation, proliferation and growth.1 In contrast, binding of lymphotoxin-β receptor (LTβR) to TRAF2 and TRAF5 propagates signals leading to activation of NF-κB,2 while binding to TRAF3 induces negative regulation of this pathway and leads to apoptosis in tumor cells.3,4 Binding recognition is mediated by specific contacts of a consensus recognition sequence in the partner with residues in a hydrophobic crevice on the TRAF molecule. Since each of these protein-protein interactions occurs within this same binding crevice, it appears that TRAF-mediated cellular mechanisms may be regulated, in part, by the level of expression or recruitment of the adaptor proteins or receptors that are competing for the crevice.The specific contacts of CD40, LTβR and BAFF-R have been defined in crystal structures of the complex with TRAF3.5–7 In addition, the downstream regulator TANK and the viral oncogenic protein LMP1 from the Epstein Barr virus also bind to the same TRAF crevice and these contacts have also been described crystallographically.8,9 Comparison of these five crystal structures has revealed that the recognition motifs in each of these proteins are accommodated in one TRAF3 binding crevice and that the binding interface is structurally and functionally adaptive.10 In this chapter, the molecular details of the interactions will be described and correlated with the functional implications for multiple TRAF3 roles in cellular regulation.

I-Traf Is A Novel Traf-Interacting Protein That Regulates Traf-Mediated Signal Transduction

TRAF3 regulates the effector function of regulatory T cells and humoral immune responses.

Protein-Protein Interactions in TRAF3

TRAF2: a Double-Edged Sword?

TNF Receptor-Associated Factor-1 (TRAF1) Negatively Regulates Toll/IL-1 Receptor Domain-Containing Adaptor Inducing IFN-beta (Trif)-Mediated Signaling.

T cell development involves TRAF3IP3-mediated ERK signaling in the Golgi.

The Roles of TRAF3 in Immune Responses.

Tumor Necrosis Factor Receptor-Associated Factor Regulation of Nuclear Factor κB and Mitogen-Activated Protein Kinase Pathways

The Tumor Necrosis Factor Receptor 2 Signal Transducers TRAF2 and C-Iap1 Are Components of the Tumor Necrosis Factor Receptor 1 Signaling Complex

The Evolving Role of TRAFs in Mediating Inflammatory Responses

TRAF1 regulates Th2 differentiation, allergic inflammation and nuclear localization of the Th2 transcription factor, NIP45

Tumor necrosis factor receptor-associated factor (TRAF)2 represses the T helper cell type 2 response through interaction with NFAT-interacting protein (NIP45)

TRAF Regulation of IL-17 Cytokine Signaling

Abstract 4277: TRAF2 is a key mediator of the EGF-induced signaling pathway.

TRAF3 enhances type I interferon (IFN I) receptor signaling in T cells through modulation of the phosphatase PTPN22

TIFAB regulates the TIFA-TRAF6 signaling pathway involved in innate immunity by forming a heterodimer complex with TIFA

TRAF3 Controls Activation of the Canonical and Alternative NFκB by the Lymphotoxin Beta Receptor

TRAF Proteins in CD40 Signaling

TRAF1 is a key mediator for hepatic ischemia/reperfusion injury

TRAF3 enhances type I interferon receptor signaling in T cells by modulating the phosphatase PTPN22

TRAF1 from a Structural Perspective